Cambridge Investment Research Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48M | Buy |
|
|||||
|
2025
Q1 | $1.29M | Buy |
|
|||||
|
2024
Q4 | $940K | Sell |
|
|||||
|
2024
Q3 | $965K | Buy |
|
|||||
|
2024
Q2 | $865K | Buy |
|
|||||
|
2024
Q1 | $658K | Buy |
|
|||||
|
2023
Q4 | $411K | Sell |
|
|||||
|
2023
Q3 | $438K | Buy |
|
|||||
|
2023
Q2 | $316K | Sell |
|
|||||
|
2023
Q1 | $461K | Sell |
|
|||||
|
2022
Q4 | $488K | Buy |
|
|||||
|
2022
Q3 | $391K | Buy |
|
|||||
|
2022
Q2 | $361K | Buy |
|
|||||
|
2022
Q1 | $441K | Sell |
|
|||||
|
2021
Q4 | $426K | Sell |
|
|||||
|
2021
Q3 | $558K | Buy |
|
|||||
|
2021
Q2 | $421K | Sell |
|
|||||
|
2021
Q1 | $570K | Buy |
|
|||||
|
2020
Q4 | $452K | Sell |
|
|||||
|
2020
Q3 | $488K | Sell |
|
|||||
|
2020
Q2 | $2.13M | Sell |
|
|||||
|
2020
Q1 | $2.74M | Buy |
|
|||||
|
2019
Q4 | $1.56M | Buy |
|
|||||
|
2019
Q3 | $219K | Buy |
|
|||||
|
2019
Q2 | $290K | Sell |
|
|||||
|
2019
Q1 | $509K | Buy |
|
|||||
|
2018
Q4 | $425K | Sell |
|
|||||
|
2018
Q3 | $640K | Sell |
|
|||||
|
2018
Q2 | $855K | Sell |
|
|||||
|
2018
Q1 | $652K | Sell |
|
|||||
|
2017
Q4 | $871K | Buy |
|
|||||
|
2017
Q3 | $692K | Buy |
|
|||||
|
2017
Q2 | $1.2M | Buy |
|
|||||
|
2017
Q1 | $989K | Buy |
|
|||||
|
2016
Q4 | $952K | Buy |
|
|||||
|
2016
Q3 | $1.2M | Buy |
|
|||||
|
2016
Q2 | $1.22M | Sell |
|
|||||
|
2016
Q1 | $1.35M | Sell |
|
|||||
|
2015
Q4 | $1.7M | Buy |
|
|||||
|
2015
Q3 | $1.38M | Buy |
|
|||||
|
2015
Q2 | $1.39M | Buy |
|
|||||
|
2015
Q1 | $1.35M | Sell |
|
|||||
|
2014
Q4 | $1.25M | Sell |
|
|||||
|
2014
Q3 | $1.22M | Buy |
|
|||||
|
2014
Q2 | $1.09M | Buy |
|
|||||
|
2014
Q1 | $823K | Buy |
|
|||||
|
2013
Q4 | $605K | Buy |
|
|||||
|
2013
Q3 | $557K | Sell |
|
|||||
|
2013
Q2 | $651K | Buy |
|